Loading Events

« All Events

  • This event has passed.

Digital Health and Mobile Medical Devices – National and Patient Organisation Priorities: The UK National Health Service and the UK Parkinson’s Disease Patient Association

June 28, 2016 @ 10:00 - 11:30 UTC+0


Webinar Topic:

Digital Health & Mobile Medical Devices – National & Patient Organisation Priorities:

The UK National Health Service & the UK Parkinson’s Disease Patient Association

Webinar Date/Time:

Tuesday, June 28, 2016 @

New York              10:00 AM – 11:30 AM

Chicago                  9:00 AM – 10:30 AM

Denver:                  8:00 AM – 9:30 AM

Los Angeles:          7:00 AM – 8:30 AM

London:                 3:00 PM – 4:30 PM

Paris:                      4:00 PM – 5:30 PM

Athens:                   5:00 PM – 6:30 PM

Sydney:                  12:00 AM – 1:30 AM

Webinar Length:

1.5 Hours (90 Minutes)

Webinar Agenda:

60 Minute Presentation

30 Minute Q&A Session

Webinar Hosts:

helen matthews

Helen Matthews - COO, The Cure Parkinson's Trust

  • Involved with CPT since its inception, and having worked alongside Tom since 2002, Helen is a PR specialist and is experienced in marketing, event planning and administration.  Helen oversees the trust's current research and patient initiative projects as well as the day to day operations and management of the charity.
doug bain

Doug Bain - Founder and Chief Technology Officer of eClinicalHealth Ltd

  • Doug has been involved in the development, deployment and optimization of eClinical technologies since 1996. eClinicalHealth provides the high performance cloud driven clinical trial solutions - Clinpal - for end-to-end clinical trial engagement and execution.

Will Maier, PhD - Chief Scientific Advisor, Mapi Group

  • Will has over 20 years of experience in drug development and commercialization at pharmaceutical companies in Europe and the United States. He was previously Senior Director of Epidemiology at GlaxoSmithKline and Elan Pharmaceuticals and led research groups conducting observational research using registries, databases, chart reviews and field research to support reimbursement, marketing and drug safety investigations of pharmaceuticals throughout the world. He has worked on over 100 observational and pragmatic studies in several disease areas including respiratory, neurology, psychiatry, autoimmune, cancer, endocrinology, cardiovascular, cerebrovascular, urology, opioid dependency, orphan drugs and vaccines. He is a member of the EMEA's European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (www.encepp.eu).  In addition, he is a frequent speaker at medical conferences and has academic appointments in the UK (Dundee) and the USA (North Carolina).

Dr. John Parkinson, PhD - Consultant Expert in Healthcare Data

  • John retired as the Director of the Clinical Practice Research Database (CPRD) and from the MHRA in June 2014. He was Director of CPRD (previously the General Practice Research Database - GPRD) from 2005 to 2014. He now acts as a Consultant to the Life Science community in the areas of Electronic Health Records (EHR), Outcomes research, Benefit/Risk, Real World Clinical Trials and overall efficiency of the clinical trial process. His twenty year experience in the Electronic Health Research area includes working on the development of the integrated health care record in Tayside Scotland, running GPRD and setting up CPRD.  His creative and enthusiastic approach to the subject is well known throughout the research community. His experience includes consultation and research in many European countries, the USA, Canada and Australia.

Webinar Description:

This webinar is the fourth in our series on the use of new Personal Health Monitoring technology in medical research and clinical medicine.

This expanded webinar will feature:

  1. How personal health monitoring technology is being implemented to improve health care at the National Health Service in England;
  2. How the Parkinson’s Disease organisation in the UK is using the new technology to improve disease understanding and better measure the impact of new therapies.

This webinar will provide an opportunity to hear directly from decision makers and leaders in these large national organisations and learn more about the similarities and differences in their approaches to the selection and application of this new health technology.

What you will learn:

  1. The UK NHS
    1. Goals and strategy
    2. Preferred methods and technology
    3. Organisation and regulatory challenges
    4. Plan for implementation
  2. The UK Parkison’s Disease Organisation
    1. Strategy and goals
    2. Preferred methods and technology
    3. Scientific and regulatory challenges
    4. Plan for implementation

Who should attend?

Pharmaceutical professionals in the following areas:

  • Medical Affairs
  • Brand Managers
  • Health Economics
  • Epidemiology
  • Clinical Research
  • Regulatory Affairs
  • Patient Engagement
  • Commercial Strategy

* Register now to attend this event: